Pancreatic Cancer Research

ResearcherTongji UniversityNo recent work listed

Bo Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0524-1105; OpenAlex author ID A5100427398. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

  1. LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Last author DOI 10.1016/j.omtn.2021.07.004↗
  2. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.102835↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongkun Wang · 2 shared papers, 2020–2021 · strength 0.25
  2. Ran Cui · 1 shared paper, 2021 · strength 0.13
  3. Ming Xu · 1 shared paper, 2021 · strength 0.13
  4. Jianying Tang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.